Open navigation
Search
Search

Select your region

Life Sciences & Healthcare Law Firm in Bulgaria

We cover every area of Life Sciences & Healthcare Law.

Latest

  • Transposition Time Updates – Nordic Trio: Denmark, Finland, and Sweden Progress Towards New EU Product Liability Directive Implementation
    12 Feb 2026 6 min read
  • Medical technologies in defence and aerospace: Key themes and emerging questions in regulation
    09 Jan 2026 7 min read
  • Positive and negative pointers in clinical trial prior art: diverging inventive step outcomes at the EPO and UPC
    08 Jan 2026 13 min read
  • Signing with e-signature in CEE 2026
    05 Jan 2026 2 min read

We work with and have established long-term relationships with the top 100 life sciences & healthcare companies in the areas of pharmaceuticals, medical devices, biotechnology, agriculture and food, including the top 20 global pharmaceutical companies and nine out of the top ten global medical device companies.  Our life sciences & healthcare teams in Central and Eastern Europe advise leading global business groups in the sector on transactions, commercial agreements, compliance, investigations and litigation, very often across multiple jurisdictions in the region and beyond. We can help you to navigate the regulatory landscape and to ensure compliance with both local laws and global policies.

With over 480 international specialist lawyers across CMS and the support of the Life Sciences & Healthcare Asia-Pacific Network (LAN), we understand the scientific and commercial as well as the legal imperatives affecting your life sciences & healthcare business. Our experts, many of whom have worked in-house in your sector, have developed a shared capability in the areas of pharmaceuticals, biotechnology, medical devices and diagnostics. With active memberships in major industry associations such as the ABPI, ABHI, BIVDA, PAGB, EUCOMED and EFPIA, we help shape the legal frameworks impacting the life sciences & healthcare sector. We regularly advise our clients on their day-to-day operational needs, providing support with advertisement and promotion of medicines, public sector procurement, pricing and reimbursement, patent enforcement and commercial and clinical trial agreements, as well as regulatory advice.

Life Sciences & Healthcare Insights

Transposition Time Updates – Nordic Trio: Denmark, Finland, and Sweden Progress Towards New EU Product Liability Directive Implementation

12 Feb 2026 6 min read

Medical technologies in defence and aerospace: Key themes and emerging questions in regulation

09 Jan 2026 7 min read

Positive and negative pointers in clinical trial prior art: diverging inventive step outcomes at the EPO and UPC

08 Jan 2026 13 min read

Signing with e-signature in CEE 2026

05 Jan 2026 2 min read

Digital health apps and telemedicine: Updated CMS Expert Guide for 30 jurisdictions

01 Dec 2025 2 min read

CMS Sofia celebrates success in the CEE Legal Matters activity rankings 2025

21 Nov 2025 1 min read

Transposition Time – Update on the EU Member States’ adoption of the new Product Liability Directive

17 Nov 2025 6 min read

CMS Expert Guide to digital health apps and telemedicine

12 Nov 2025 2 min read

Events

  • Bulgaria
    18 Mar 2026

    Green claims in focus

  • Bulgaria
    19 Mar 2026

    CMS Nordic Health Summit

  • Bulgaria
    23 Mar 2026

    CMS at PTMG Spring 2026

  • Bulgaria
    08 Apr 2026

    CMS at Fordham IP & Policy Conference

  • Bulgaria
    21 Apr 2026

    On the Pulse webinar series 2026 - Spring/Summer

  • Bulgaria
    28 Apr 2026

    IP Insights webinar series 2026

Back to top Back to top
Warning: Fraudulent emails and messages